Predictors of Clinically Important Improvements in Motor Function and Daily Use of Affected Arm after a Botulinum Toxin A Injection in Patients with Chronic Stroke
Identifying patients who can gain minimal clinically important difference (MCID) in active motor function in the affected upper extremity (UE) after a botulinum toxin A (BoNT-A) injection for post-stroke spasticity is important. Eighty-eight participants received a BoNT-A injection in the affected U...
Main Authors: | Jen-Wen Hung, Wen-Chi Wu, Yi-Ju Chen, Ya-Ping Pong, Ku-Chou Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/1/13 |
Similar Items
-
Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke
by: Ana Maria Bumbea, et al.
Published: (2023-11-01) -
Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries
by: Raymond L. Rosales, et al.
Published: (2024-04-01) -
Feasibility of Video Clip Analysis on Effect of Botulinum Toxin-A Injection for Post-Stroke Upper Limb Spasticity
by: Nam-Jong Paik, et al.
Published: (2013-05-01) -
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
by: Nick Steen, et al.
Published: (2012-11-01) -
Upper Extremity Deep Vein Thrombosis After Botulinum Toxin Injection: A Case Report
by: Nana Lim, et al.
Published: (2021-04-01)